Reheis Inc

Reheis, Inc., along with General Chemical Corporation and Printing Developments, Inc. (PDI), form the Performance Products Segment of GenTek Inc. (NYSE: GK). A spin-off from the General Chemical Group in April 1999, GenTek Inc. is a leading manufacturer of telecommunications equipment, industrial components and performance products. Over the years, Reheis has been at the leading edge of technology in the fields of antiperspirants and antacids. This is most clearly evidenced by the ever growing number of Reheis new products. These advancements come not only from research undertaken independently by the company, but also in conjunction with our customers to meet their specific needs. Reheis also uses this leading edge approach in the area of adsorbents to the biomedical and veterinary vaccine industries, and potassium chloride to the pharmaceutical and food industries.

Activity:

Product / Technology type(s) covered:

- Bio
- Generics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: North America , Europe

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: